| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.072 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |